13-cis Retinoic Acid Induces Apoptosis and Cell Cycle Arrest in Human SEB-1 Sebocytes  by Nelson, Amanda M. et al.
13-cis Retinoic Acid Induces Apoptosis and Cell Cycle
Arrest in Human SEB-1 Sebocytes
Amanda M. Nelson1, Kathryn L. Gilliland1, Zhaoyuan Cong1 and Diane M. Thiboutot1,2
Isotretinoin (13-cis retinoic acid (13-cis RA)) is the most potent inhibitor of sebum production, a key component
in the pathophysiology of acne, yet its mechanism of action remains largely unknown. The effects of 13-cis RA,
9-cis retinoic acid (9-cis RA), and all-trans retinoic acid (ATRA) on cell proliferation, apoptosis, and cell cycle
proteins were examined in SEB-1 sebocytes and keratinocytes. 13-cis RA causes significant dose-dependent and
time-dependent decreases in viable SEB-1 sebocytes. A portion of this decrease can be attributed to cell cycle
arrest as evidenced by decreased DNA synthesis, increased p21 protein expression, and decreased cyclin D1.
Although not previously demonstrated in sebocytes, we report that 13-cis RA induces apoptosis in SEB-1
sebocytes as shown by increased Annexin V-FITC staining, increased TUNEL staining, and increased cleaved
caspase 3 protein. Furthermore, the ability of 13-cis RA to induce apoptosis cannot be recapitulated by 9-cis RA
or ATRA, and it is not inhibited by the presence of a retinoid acid receptor (RAR) pan-antagonist AGN 193109.
Taken together these data indicate that 13-cis RA causes cell cycle arrest and induces apoptosis in SEB-1
sebocytes by a RAR-independent mechanism, which contributes to its sebosuppressive effect and the
resolution of acne.
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INTRODUCTION
Isotretinoin (13-cis retinoic acid (13-cis RA)) is the most
potent inhibitor of sebum production, a key component in the
pathophysiology of acne. It is the only retinoid that
dramatically reduces the size and secretion of sebaceous
glands (Landthaler et al., 1980; Strauss et al., 1980; Goldstein
et al., 1982). Despite the fact that isotretinoin is extremely
effective against acne, surprisingly little is known regarding
its molecular mechanism of action although advances are
being made in this area. This unique retinoid has been shown
to competitively inhibit the 3a-hydroxysteriod activity of
retinol dehydrogenase leading to decreased androgen synth-
esis in vitro as well as inhibit the migration of polymorpho-
nuclear leukocytes into the skin supporting its role in the
reduction of inflammation that is associated with acne
(Wozel et al., 1991; Karlsson et al., 2003).
Numerous studies indicate that 13-cis RA and other reti-
noids affect cell cycle progression, differentiation, apoptosis,
and cell survival in a variety of cell types including human
breast cancers, oral squamous cell carcinomas, lymphocytes,
and murine neurons (Pomponi et al., 1996; Giannini et al.,
1997; Toma et al., 1997; Cariati et al., 2000; Crandall et al.,
2004; Sakai et al., 2004). Like previous studies in other cell
types, 13-cis RA has also been shown to decrease prolifera-
tion of sebocytes and inhibit sebocyte differentiation as
indicated in histology specimens, primary sebocytes, and
SZ95 immortalized human sebocytes (Doran et al., 1980;
Jones et al., 1980; Landthaler et al., 1980; Strauss et al., 1980;
Ridden et al., 1990; Zouboulis et al., 1991a, b, 1999).
Although increased levels of caspase 3 were noted in SZ95
sebocytes 24 hours following treatment with 13-cis RA and
inhibition of cell growth was evident at 7 days, other markers
failed to indicate that SZ95 sebocytes were undergoing
apoptosis (Zouboulis et al., 1993; Wrobel et al., 2003). We
hypothesized that 13-cis RA reduces sebocyte cell counts via
cell cycle arrest and/or apoptosis and that these effects might
not be apparent within a 24-hour treatment period.
In this paper, we report that after 48 and 72 hours of
treatment 13-cis RA, but not 9-cis retinoic acid (9-cis RA) or
all-trans retinoic acid (ATRA), inhibits growth and induces
apoptosis in immortalized human SEB-1 sebocytes but not in
HaCaT keratinocytes or normal human epidermal keratino-
cytes (NHEK). Furthermore, the RAR pan antagonist, AGN
193109, does not inhibit the apoptosis induced by 13-cis RA
suggesting an RAR-independent apoptotic mechanism. We
hypothesize that the ability of 13-cis RA to induce cell
cycle arrest and apoptosis in sebocytes contributes to the
overall effect on suppression of sebum and improvement
in acne.
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Results
13-cis RA exhibits a more rapid onset of growth inhibition of
SEB-1 sebocytes compared to 9-cis RA or ATRA
There is a significant dose-dependent decrease in cell count
after 48 and 72 hours of treatment with 13-cis RA (Figure 1a).
At 48 hours, 13-cis RA concentrations of 0.1, 0.5, and 1 mM
decreased cell count by 19, 22, and 30% respectively, when
compared to vehicle (Po0.05). After 72 hours cell numbers
decreased by 19, 43, and 39% with 13-cis RA concentrations
of 0.1 mM (Po0.01), 0.5mM (Po0.0001), and 1 mM (Po0.05)
respectively. No significant differences in cell number were
noted at 24 hours of treatment.
The effects of 9-cis RA and ATRA on SEB-1 sebocyte
counts were noted beginning at 72 hours. Decreases of 39
and 43% were noted with 9-cis RA (0.5 and 1 mM,
respectively) (Po0.05) (Figure 1b). ATRA (0.1 and 1 mM)
significantly decreased cell number by 14 and 37%,
respectively (Po0.05) (Figure 1c). Overall, each of these
three retinoids decreased SEB-1 sebocyte numbers at
72 hours albeit to varying degrees but effects were noted
beginning at 48 hours with 13-cis RA.
13-cis RA significantly inhibits DNA synthesis in SEB-1
sebocytes
13-cis RA (0.1, 0.5, and 1 mM) each significantly decreased
thymidine incorporation by approximately 3-fold at 72 hours
(Po0.01) (Figure 2a). No significant changes were noted at
24 or 48 hours. A 1.85-fold decrease in 3H thymidineControl
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Figure 1. 13-cis RA, 9-cis RA, and ATRA differentially inhibit SEB-1 sebocyte
proliferation. (a–c) Time-dependent inhibition of SEB-1 cell proliferation with
individual retinoid compounds. SEB-1 cells were cultured in the presence of
ethanol vehicle alone (0.01% or less; control) 0.1, 0.5, or 1 mM concentrations
of 13-cis RA, 9-cis RA, or ATRA for 24, 48, or 72 hours. Attached cells were
collected, stained with Trypan blue, and viable cells counted manually by
hemocytometer. Data represent mean7SEM, n¼ 12. Statistical analysis was
performed with ANOVA Two Factor with Replication. *Po0.05, **Po0.01,
and ***Po0.0001.
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Figure 2. 13-cis RA inhibits DNA synthesis to a greater extent than 9-cis RA
or ATRA. (a–c) SEB-1 sebocytes were treated with ethanol vehicle (control) or
0.1, 0.5, 1 mM concentrations of 13-cis RA, 9-cis RA, or ATRA for 24, 48, and
72 hours. 1mCi 3H thymidine was added to each sample 8 hours before
harvesting. Cells were washed and collected for liquid scintillation counting.
Data represent mean7SEM, nX12. Statistical analysis was performed with
ANOVA Two Factor with Replication. *Po0.05 and **Po0.01.
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incorporation was noted when cells were treated with 1 mM
9-cis RA for 48 hours (Figure 2b). ATRA in concentrations of
0.5 and 1 mM decreased thymidine incorporation by approxi-
mately 1.8–fold at 24 and 72 hours, respectively (Figure 2c).
13-cis RA, but not 9-cis RA or ATRA, increases p21 levels in
SEB-1 sebocytes
To further test the hypothesis that 13-cis RA changes cell
cycle progression, expression of p21, a cell cycle inhibitor,
was examined by Western blot. 13-cis RA significantly
increased p21 expression after 48 and 72 hours of treatment
(Figure 3a). Specifically, p21 levels increased on average
2.64-fold and 3.13-fold when cells were treated with 0.1 mM
13-cis RA and 1 mM 13-cis RA, respectively, for 48 hours
(P¼0.008 and 0.05). After 72 hours of treatment, all concen-
trations tested increased p21 protein expression. 13-cis RA
caused 1.47-, 2.27-, and 3.01-fold increases in p21 with
0.1, 1, and 10 mM 13-cis RA, respectively. No significant
differences in p21 expression were noted at 24 hours (data
not shown). When SEB-1 sebocytes were treated with 9-cis
RA or ATRA in concentrations of 0.1, 0.5, and 1 mM, no
significant increases in p21 protein were noted at 48 or
72 hours (Figure 3b and c).
13-cis RA, but not 9-cis RA or ATRA, decreases cyclin D1
protein in SEB-1 sebocytes
To further explore the possibility that 13-cis RA induces a G1
arrest in SEB-1 sebocytes, cyclin D1 protein was examined by
Western blot. Cyclin D family members are expressed and
function in controlling the progression from G1 to S phase in
the cell cycle (Baldin et al., 1993). Overexpression of cyclin
D1 shortens the duration of G1 phase and is rate limiting for
phase progression (Quelle et al., 1993). Therefore, cyclin D1
is a likely candidate to confirm the actions of 13-cis RA in
inhibiting cell cycle progression by influencing the G1 to S
phase transition. In SEB-1 sebocytes, 13-cis RA in concentra-
tions of 0.1, 1, and 10 mM, significantly decrease cyclin D1
protein at 72 hours (Figure 3d). No significant effects of 13-cis
RA were noted at 24 or 48 hours (24-hour data not shown).
9-cis RA or ATRA concentrations of 0.1, 0.5, or 1 mM did not
reduce cyclin D1 protein at 72 hours (data not shown).
13-cis RA induces apoptosis in SEB-1 sebocytes but not in
HaCaT keratinocytes or NHEK
To determine if the effect of 13-cis RA on apoptosis is cell-
type specific, time course experiments were conducted in
SEB-1 sebocytes, HaCaT keratinocytes, and NHEK. In SEB-1
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Figure 3. 13-cis RA increases p21 and decreases cyclin D1 proteins. (a) SEB-1 cells were treated with 0.1, 1, and 10 mM 13-cis RA or vehicle. (b and c) Parallel
experiments were performed with 0.1 0.5, or 1 mM concentrations of 9-cis RA and ATRA. Blots were incubated with primary antibodies to p21 and b-actin for
loading control normalization and analyzed by densitometry. (d) SEB-1 cells were treated with 0.1, 1, and 10 mM 13-cis RA or vehicle and blots were incubated
with primary antibodies to cyclin D1 and b-actin. Magic Mark XP (MM) indicates band size. Blots are representative of minimum of three Western blots. Graphs
represent normalized values relative to vehicle (control) expression of a minimum of three independent Western blots. Mean7SEM. *Po0.05 and **P¼ 0.01.
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sebocytes, no significant differences in apoptosis were noted
in cells treated with 13-cis RA for 2, 4, 6, or 24 hours. A
marginal, yet significant, increase in the percentage of cells in
early apoptosis was noted in SEB-1 cells treated with 0.1 mM
13-cis RA: 2.03–2.49% at 48 hours and from 2.19 to 2.84% at
72 hours (Po0.01 for each time point). Significant increases
in the percentage of cells in late apoptosis were noted at 48
and 72 hours with increasing concentrations of 13-cis RA
(Figure 4a, late apoptosis shown). Specifically, 0.1 mM 13-cis
increased the percentage of late apoptosis: 4.06–5.22% at
48 hours and 5.31–8.11% at 72 hours. 13-cis RA at 1 mM
concentration caused increases from 3.64 to 5.08% and from
7.57 to 12.18% at 48 and 72 hours, respectively. Nanomolar
concentrations of 13-cis RA did not induce apoptosis at any
of the time points examined (data not shown).
In HaCaT keratinocytes, no significant differences in the
percentages of cells in early and late apoptosis or necrosis
were noted in cells treated with 0.1 mM 13-cis RA at all time
points examined. 13-cis RA (1mM) significantly increased the
percentage of cells in early and late apoptosis at 24 and
48 hours, respectively. Yet these increases were very minor,
with the total percentage of HaCaT cells in apoptosis with
13-cis RA being o2% of the cells (Figure 4b, late apoptosis
shown). In experiments with NHEK cells, no significant
differences in the percentages of cells in early or late
apoptosis or necrosis were noted in cells treated with 13-cis
RA with the exception of an increase from 5.25 to 6.2% in
late apoptosis at 2 hours in cells treated with 1 mM 13-cis RA
(Figure 4c, late apoptosis shown). Apoptosis was significantly
induced by staurosporine in SEB-1 sebocytes, HaCaT
keratinocytes and NHEK. No significant differences were
noted between standard medium and ethanol controls in any
cell type at any time point during these studies indicating that
the concentrations of ethanol used in these experiments did
not induce apoptosis.
13-cis RA specifically increases levels of cleaved caspase 3 in
SEB-1 sebocytes
SEB-1 sebocytes were treated with 13-cis RA and four
independent Western blots were run to detect cleaved
caspase 3. No cleaved caspase 3 was noted at 24 hours
in negative control lanes or in cells treated with 13-cis RA.
13-cis RA significantly increased cleaved caspase 3 levels at
48 and 72 hours in SEB-1 sebocytes (Figure 5a). Specifically,
0.1 mM 13-cis RA and 1 mM 13-cis RA increased expression of
cleaved caspase 3 on average 3.58-fold (Po0.01) and 3.33-
fold (Po0.01), respectively, at 48 hours. Small fold increases
were noted at 72 hours that were not statistically significant.
Although the magnitude of the increase in cleaved caspase 3
is greatest with 10 mM 13-cis RA at 48 hours, these results
were not statistically significant; due to the variability
induced by the very limited survival of cells at this higher
concentration.
To determine if the induction of apoptosis is a specific to
13-cis RA, SEB-1 sebocytes were also treated with 0.1, 0.5, or
1 mM concentrations of 9-cis RA and ATRA. Again, no cleaved
caspase 3 was detected at 24 hours in negative controls or
with any concentration of either retinoid. Furthermore, unlike
the case with 13-cis RA, no significant increases in cleaved
caspase 3 were noted with either 9-cis RA or ATRA at 48 and
72 hours (Figure 5b and c).
For additional confirmation that the apoptotic effect of 13-
cis RA is specific to SEB-1 sebocytes, Western blots for
cleaved caspase 3 were performed on NHEK. No cleaved
caspase 3 could be detected at any time point examined in
NHEK cells treated with 13-cis RA. However, cleaved
caspase 3 was detected when NHEK were treated with 1 mM
staurosporine indicating that these cells are capable of
undergoing apoptosis (Figure 6). In summary, 13-cis RA
specifically induces apoptosis in a dose-dependent manner in
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Figure 4. 13-cis RA induces late apoptosis in SEB-1 sebocytes but not in
HaCaT keratinocytes or NHEK. (a) SEB-1 cells were treated with vehicle
(negative control), 13-cis RA (0.1 or 1 mM), or staurosporine (S) (positive
control) for indicated times. (b) HaCaT cells were treated with vehicle, 13-cis
RA (0.1 or 1 mM), or staurosporine (S) for the indicated times. (c) NHEK cells
were treated with vehicle, 13-cis RA (0.1 or 1 mM), or staurosporine (S) for
indicated times. In all experiments, cells were prepared according to
manufacturer’s protocol for Annexin V-FITC / PI staining (BD ApoAlert, BD
Biosciences). Data were analyzed with Cell Quest Software and represent
mean7SEM, nX12. Statistical analysis was performed with ANOVA Two
Factor with Replication. *Po0.01 and **Po0.00001.
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SEB-1 sebocytes but not in NHEK. Furthermore, 9-cis RA or
ATRA does not induce apoptosis in SEB-1 sebocytes.
13-cis RA, but not 9-cis or ATRA, increases TUNEL staining in
SEB-1 sebocytes
To further test the hypothesis that 13-cis RA induces apoptosis
and to confirm the results from the Annexin V-FITC
experiments in SEB-1 sebocytes, we examined the effects of
13-cis RA on SEB-1 cells by TUNEL assay. 13-cis RA (0.1 and
1 mM) increased the percentage of TUNEL-positive cells by
3.5- and 5.67-fold, respectively (Pp0.01) at 48 hours, while
each concentration of 13-cis RA increased the percentage of
TUNEL-positive cells by approximately 13-fold at 72 hours
(Pp0.01) (Figure 7b). No differences were noted at 24 hours
(data not shown). To compare the actions of 13-cis RA to its
isomerization products, SEB-1 sebocytes were also treated
with the same concentrations of 9-cis RA and ATRA and no
significant increases in TUNEL-stained cells were noted at
any time point examined (Figure 7a and b). Both 9-cis RA and
ATRA had 1–3% TUNEL-positive cells at time points
examined. Fenretinide treatment of SEB-1 sebocytes signifi-
cantly increased the percentage of TUNEL-positive cells in a
dose-dependent fashion at 48 and 72 hours (ranging from 15
to 85% positive cells) (Figure 7a and b). No significant
increase in the percentage of TUNEL-positive cells was noted
with retinoid X receptor (RXR) pan agonist, CD 3254 at
48 hours. However, 50 nM CD 3254 significantly increased
TUNEL-positive cells from 3 to 48% at 72 hours (Po0.01)
(data not shown).
Apoptosis induction by 13-cis RA in SEB-1 sebocytes is not
blocked by RAR antagonist AGN 193109
To determine if the effects of 13-cis RA on apoptosis are
mediated by RA receptors, SEB-1 sebocytes were treated with
1 mM 13-cis RA in the presence of 10 mM AGN 193109, an
RAR pan antagonist, and the TUNEL assay was performed.
13-cis RA alone significantly increased the percentage of
cells in apoptosis over vehicle control by approximately
5-fold at 48 and 72 hours (Po0.05). These increases were not
inhibited in the presence of AGN 193109 at 48 and 72 hours
(Figure 7c and d) (48-hour data not shown). To verify the
activity of AGN 193109 within our cells at the time points
examined in the TUNEL assay, we performed quantitative
PCR for RAR responsive gene, tazarotene-induced gene 1
(TIG1). RAR activation induces the expression of TIG1
(Nagpal et al., 1996). In the presence of 1mM 13-cis RA
alone, TIG1 expression was approximately 13- and 17-fold
higher than controls at 48 and 72 hours, respectively. With
the addition of AGN 193109, TIG1 gene expression
dramatically decreases at 48 and 72 hours and is lower than
vehicle-treated controls (Figure 7e).
13-cis RA is isomerized to ATRA over time in SEB-1 sebocytes
To study the kinetics of 13-cis RA uptake in SEB-1 sebocytes
and its possible isomerization to ATRA or 9-cis RA, SEB-1
sebocytes were treated with 13-cis RA and subjected to HPLC
analysis. 13-cis RA remains relatively stable in standard
culture medium for approximately 24 hours (Figure 8a). The
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Figure 5. 13-cis RA increases cleaved caspase 3 protein in SEB-1 sebocytes.
(a) SEB-1 sebocytes were treated with vehicle, 0.1, 1, or 10mM 13-cis RA. (b
and c) Parallel experiments were performed with 0.1, 0.5, or 1 mM
concentrations of 9-cis RA or ATRA. Blots were incubated with primary
antibodies to cleaved caspase 3 (1:1,000) and actin (1:1,000) for loading
control normalization and analyzed by densitometry. p17 and p19 are
cleaved caspase 3 fragments. Blots are representative of a minimum of four
independent experiments. Graph represents normalized values relative to
vehicle (control) expression for four independent Western blots. Data
represent mean7SEM *Po0.01.
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concentration of 13-cis RA in standard culture medium alone
is similar to the concentration in medium from SEB-1
sebocyte-containing plates (Figure 8a and b). The concentra-
tions of 13-cis RA within SEB-1 sebocytes increases to a
maximum of 350 ng/ml at 12 hours, at which point the
concentration declines for the duration of the experiment
(Figure 8c). The concentration of ATRA in the medium alone
and from plates containing SEB-1 sebocytes was much lower
than 13-cis RA concentrations at the corresponding time
points. The concentration of ATRA within SEB-1 sebocytes
begins to rise at 12 hours and continues through the
remaining time periods. 9-cis RA concentrations are minimal
at best in medium alone and medium from SEB-1 plates
during the time course. Within SEB-1 sebocytes, 9-cis RA
concentrations range from 1.4 ng/ml at 0 hour to a maximum
of 12 ng/ml at 72 hours, magnitudes lower than either 13-cis
RA or ATRA at the same time periods (Figure 8).
DISCUSSION
Determining the actions of isotretinoin on the sebaceous
gland is essential in advancing our understanding of the
molecular mechanism of action of this drug and in our search
for safer therapeutic alternatives. Several studies indicate that
the effects of retinoids on cell proliferation, cell cycle, and
apoptosis are retinoid specific or cell-type specific. For
example, growth inhibition with 13-cis RA has been reported
in human breast cancer cell lines, primary glioblastoma cells,
Epstein–Barr virus-immortalized B lymphocytes, and oral
squamous cell carcinoma cell lines (Pomponi et al., 1996;
Giannini et al., 1997; Toma et al., 1997; Bouterfa et al.,
2000). In some cases the effects noted with 13-cis RA or 9-cis
RA were not duplicated by ATRA (Bouterfa et al., 2000). Most
studies in other cell types suggest that retinoids cause a block
in the G1/S phase of the cell cycle triggering decreased S
phase and increased the percentage of cells in G0/G1
(Giannini et al., 1997; Toma et al., 1997; Crandall et al.,
2004). It is also well established that retinoids induce
apoptosis in numerous cell types, both normal cells and
tumor cell lines, although not previously demonstrated in
sebocytes. For example, in doses comparable to those given
for the treatment of acne in humans, 13-cis RA reduces the
survival and genesis of murine hippocampal neurons in vivo
(Crandall et al., 2004; Sakai et al., 2004). ATRA has been
shown to induce apoptosis in primary and metastatic
melanoma cells (Zhang and Rosdahl, 2004) as well as
inducing growth arrest followed by apoptosis in orbital
fibroblasts from patients with Graves’ disease (Pasquali et al.,
2003). In OCI/AML-2 retinoid-sensitive cell line subclones
derived from leukemia cells, 9-cis RA inhibited cell growth
and induced apoptosis to a greater extent than 13-cis RA or
ATRA (Koistinen et al., 2002). These studies demonstrate that
the actions of retinoids are unique and specific to the model
used.
The exact mechanism of action of 13-cis RA in the
treatment of acne remains largely unknown. 13-cis RA has
little to no ability to bind to cellular retinol-binding proteins
or the RA nuclear receptors (RARs and RXRs) (Levin et al.,
1992; Allenby et al., 1993; Fogh et al., 1993). It has been
suggested 13-cis RA may, in fact, act as a pro-drug that is
isomerized intracellularly to ATRA, an agonist for RAR
nuclear receptors, and 9-cis RA, which is a non-specific
agonist for both RAR and RXR nuclear receptors (Allenby
et al., 1993; Ott et al., 1996). Studies of immortalized human
sebocyte line SZ95 showed that 13-cis RA is preferentially
metabolized to ATRA, which can bind to and activate RAR,
which leads to the overall inhibition of sebocyte proliferation
(Tsukada et al., 2000). Our studies confirm that 13-cis RA is
primarily metabolized to ATRA in SEB-1 sebocytes beginning
at 24 hours. It is well established, however, that 13-cis RA is
superior to either 9-cis RA or ATRA for sebosuppression
(Geiger et al., 1996; Hommel et al., 1996; Ott et al., 1996).
Alternatively, 13-cis RA may act in a receptor independent
manner by influencing cellular signaling pathways by direct
protein interactions as demonstrated with other retinoids or
by enzyme inhibition (Zorn and Sauro, 1995; Hoyos et al.,
2000; Imam et al., 2001; Karlsson et al., 2003).
Previous studies have examined the actions of 13-cis RA,
9-cis RA, and ATRA on cultured human sebocytes, SZ95
immortalized sebocytes, and rat preputial cells (Zouboulis
et al., 1991a, 1993; Tsukada et al., 2000; Wrobel et al.,
2003). 13-cis RA at concentrations greater than 107 M and
ATRA (105 to 106 M) significantly decreased human
sebocyte proliferation after 7 or 14 days (Zouboulis et al.,
1991a, 1993). Studies of immortalized human sebocytes
SZ95, showed that 13-cis RA, 9-cis RA, and ATRA at
concentrations of 107 M significantly reduced proliferation
by approximately 50% after 9 days (Tsukada et al., 2000). In
primary rat preputial cells, ATRA and other RAR-selective
agonists significantly decreased cell numbers after 9 days
(Kim et al., 2000).
Processes such as cell cycle arrest or apoptosis may
explain the histological data in human skin biopsies that
demonstrates a drastic decrease in the size, shape, and lipid
content of sebaceous glands after 16 weeks of isotretinoin
(Goldstein et al., 1982) Since proliferation studies in SZ95
sebocytes suggested that the effects of 13-cis RA and other
retinoids may be noted after 7–9 days, we designed
experiments to look at the effects of 13-cis RA, 9-cis RA,
and ATRA on proliferation, cell cycle progression, and
apoptosis in SEB-1 sebocytes at time points later than 24
hours but prior to 7 days. Our proliferation studies show that
13-cis RA causes a dose-dependent decrease in cell count
after 48 and 72 hours whereas 9-cis RA and ATRA show
significant decreases beginning at 72 hours. We would expect
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that if our experiments were extended, the magnitude of this
decrease would be greater as previously reported in SZ95
sebocytes after 9 days (Tsukada et al., 2000). Overall, 13-cis
RA at the concentrations tested in our study acts sooner in
inhibiting proliferation than either 9-cis RA or ATRA. These
data are supported by studies demonstrating an approximate
3-fold decrease in 3H thymidine incorporation in SEB-1
sebocytes that were treated with 13-cis RA for 72 hours. This
decrease is nearly 2-fold greater than the decreases produced
by 9-cis RA or ATRA. This experiment suggests that 13-cis RA
is more potent at growth inhibition than either 9-cis RA or
ATRA in SEB-1 sebocytes.
Further supporting the hypothesis that 13-cis RA causes a
block in the G1/S phase as demonstrated in other cell types,
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we show that 13-cis RA increases p21 protein and decreases
cyclin D1 protein at 48 and 72 hours. Cyclin D1 protein
expression decreases by approximately 50% at 72 hours,
which coincides with our 3H thymidine studies where 13-cis
RA had the most striking effect at 72 hours. Furthermore,
cyclin D1 was not decreased with 9-cis RA or ATRA at
72 hours, which is also consistent with our 3H thymidine
studies. No significant increases in p21 protein were noted
with 9-cis RA or ATRA although increasing trends were
noted. Taken together, these experiment show that in SEB-1
sebocytes, 13-cis RA is much more effective than 9-cis RA or
ATRA in both decreasing the proportion of cells synthesizing
DNA and inducing a G1/S phase cell cycle block by
increasing p21 and decreasing cyclin D1 expression.
Studies in SZ95 sebocytes did not demonstrate apoptosis
in cells treated up to 24 hours with 13-cis RA (105 to 108 M)
and assayed by DNA fragmentation and lactate dehydrogen-
ase release (Wrobel et al., 2003). At 24 hours, no changes in
apoptosis were noted when SZ95 sebocytes were treated with
107 M 13-cis RA as assessed by annexin V staining, cell
death assays, or FACS analysis and reverse transcriptase-PCR
for the apoptotic proteins, bcl-2 and bax. Interestingly, in
SZ95 sebocytes, 13-cis RA increased levels of caspase 3 as
detected by FACS analysis at 24 hours. Accordingly, in our
studies of SEB-1 sebocytes, no increase in apoptosis was
noted 24 hours after treatment with 13-cis RA as assayed by
Annexin V-FITC FACS. However, increases in early and late
apoptosis were noted at 48 and 72 hours with concentrations
of 13-cis RA similar to those used in SZ95 sebocytes,
although the magnitude of the number of cells in apoptosis
is small compared to the positive control, staurosporine.
In contrast, the magnitude of the changes in apoptosis
induced by 13-cis RA was much greater in the TUNEL
assay. By extending the treatment times in our assay we were
able to detect the induction of apoptosis by 13-cis RA,
which was verified by increased expression of cleaved
caspase 3. Furthermore, the increase in apoptosis was limited
to 13-cis RA as no significant increases in apoptosis were
noted when SEB-1 sebocytes were treated with 9-cis RA
or ATRA.
The effects of 13-cis RA on apoptosis and growth
inhibition may or may not be mediated by retinoid receptors.
It is possible that the effects of 13-cis RA on apoptosis and
growth inhibition may be mediated by other isomerization
products such as 4-oxo-isotretinoin or 4-hydroxy-isotretinoin
(Orfanos and Zouboulis, 1998). The 4-oxo metabolites of
retinoids have been shown to be functionally active in human
keratinocytes and fibroblasts by their ability to induce
changes in gene expression (Baron et al., 2005). Our data
show that RAR pan antagonist AGN 193109 sufficiently
blocks RAR activation in the presence of 13-cis RA as
measured by a significant decrease in TIG1 gene expression,
yet does not block apoptosis induced by 13-cis RA in SEB-1
sebocytes, thus supporting the hypothesis that apoptosis
induction by 13-cis RA is independent of RAR activation.
Alternatively, apoptosis may be mediated through RXR
nuclear receptor activation (Zhao et al., 2004). Using the
RXR pan agonist CD 3254 (50 nM), a significant increase in
the percentage of TUNEL-positive SEB-1 sebocytes was noted
at 72 hours. Although our HPLC data indicate very low levels
of 9-cis RA (a maximum of 12 ng/ml at 72 hours), RXR
activation by 9-cis RA is possible (Allenby et al., 1993) or 13-
cis RA may be metabolized to another as yet unidentified
metabolite that is capable of RXR activation.
Alternatively, 13-cis RA may have effects that are
independent of retinoid receptors. Interestingly, we showed
that fenretinide, a retinoid known to induce apoptosis
primarily by RAR- and RXR-independent means is able to
induce significant apoptosis in our SEB-1 sebocytes. In fact,
the degree of apoptosis induced by fenretinide at 48 hours is
very similar to that observed with 13-cis RA treatment at
72 hours. Fenretinide induces apoptosis by elevating reactive
oxygen species and increases in activation of ceramide and
caspases (Wu et al., 2001). In addition, a retinoid-related
molecule, AGN 193198 induces apoptosis without activation
of the classical retinoid receptors (Keedwell et al., 2004;
Balasubramanian et al., 2005). It may be possible that 13-cis
RA acts similarly to fenretinide or AGN 193198 via
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receptor-independent mechanisms; although additional ex-
periments are required to test this hypothesis.
Since the actions of retinoids differ in various cell types
and the effects of 13-cis RA are most profound on sebaceous
glands in vivo, it is possible that the induction of apoptosis
and cell cycle arrest may be specific to sebocytes since 13-cis
RA failed to induce apoptosis in HaCaT keratinocytes or
NHEK. It is possible that with higher concentrations of 13-cis
RA or longer treatment times that apoptosis may be induced
in keratinocytes. Although there is no evidence in the
literature of 13-cis RA-induced apoptosis in keratinocytes,
ATRA, and tazarotene, an RARb/g-selective agonist, have
been shown to induce apoptosis in HaCaTs (Louafi et al.,
2003; Papoutsaki et al., 2004). Taken together, these
experiments support the hypothesis that 13-cis RA specifi-
cally induces apoptosis in SEB-1 sebocytes and not keratino-
cytes.
In conclusion, our data indicate that 13-cis RA inhibits
growth and induces apoptosis in SEB-1 sebocytes and not
keratinocytes at concentrations that are therapeutically
achievable in human plasma (Rollman and Vahlquist, 1986;
Adamson, 1994; Almond-Roesler et al., 1998). Previous
studies in human sebocytes and immortalized sebocytes have
also documented growth inhibition with 13-cis RA, however,
we have extended these studies to show that this growth
inhibition is most likely due to influencing the G1/S phase of
the cell cycle as evidenced by decreased DNA synthesis,
increased p21 protein, and decreased cyclin D1 protein. In
addition, we report for the first time, that 13-cis RA also
induces apoptosis in SEB-1 sebaceous cells. The ability of
13-cis RA to induce apoptosis is specific to sebocytes, not
keratinocytes, and is distinct from effects observed with 9-cis
RA and ATRA that may account, in part, for the superior
efficacy of 13-cis RA in reducing sebum production.
Furthermore, the induction of apoptosis by 13-cis RA does
not appear to involve RAR nuclear receptors. Elucidating the
cellular processes that are affected by 13-cis RA in sebocytes
is a step toward understanding the overall molecular
mechanism of action of this drug, which may lead to the
identification of alternative strategies for the treatment of
acne.
MATERIALS AND METHODS
Cell culture
The SEB-1 human sebocyte cell line was generated by transfection of
secondary sebocytes by SV40 Large T antigen as previously
described (Thiboutot et al., 2003). SEB-1 cells were cultured and
maintained in standard culture medium containing: 5.5 mM low
glucose DMEM 3:1 Ham’s F12, 2.5% fetal bovine serum, hydro-
cortisone 0.4 mg/ml, adenine 1.8 104 M, insulin 10 ng/ml, epider-
mal growth factor 3 ng/ml, cholera toxin 1.2 1010 M, and
antibiotics.
HaCaT keratinocytes were cultured and maintained in 5.5 mM
low glucose DMEM, 5% fetal bovine serum, and antibiotics and
served as a control cell line in Annexin V-FITC FACS apoptosis
assays. NHEK-neonatal (pooled) (NHEK-neo, Clonetics Keratinocyte
System, Cambrex Bioscience, Walkersville, MD) were cultured in
keratinocyte growth medium-2 (Cambrex Bioscience, Walkersville,
MD). NHEK-neo cells served as control cells in Annexin V-FITC
FACS apoptosis assays and Western blots for cleaved caspase 3.
Effects of retinoids on SEB-1 proliferation
Retinoid compounds were purchased through SIGMA (St Louis,
MO): 13-cis RA (R 3255), 9-cis RA (R 4653) and ATRA (R 2625).
Stock solutions of retinoids were handled under dimmed yellow
light, dissolved in 100% ethanol at a concentration of 10 mM, and
stored under N2 gas at 201C until use. The RAR pan antagonist
AGN 193109 was obtained from Allergan (gift, Dr Rosh Chandrar-
atna) and dissolved in DMSO at a concentration of 10 mM, and
stored at 701C until use. Treatments were made from retinoid
stocks diluted to the appropriate concentration in standard culture
mediums solutions under dimmed yellow light. Staurosporine (S
5921, Sigma, St Louis, MO) was solubilized in 100% ethanol at a
concentration of 10 mM, stored at 201C, and diluted to desired final
concentration in appropriate cell culture medium for a positive
control for apoptosis.
SEB-1 sebocytes (passages 20–23) were seeded at 4 104 cells
per 35-mm plate and grown until approximately 40% confluent.
Plates were each treated with 0.1, 0.5, 1mM concentrations of 13-cis
RA, 9-cis RA, ATRA, or ethanol vehicle alone (0.01% or less) in
triplicate for 24, 48, and 72 hours. Cells were detached using trypsin
(0.05%), collected, and diluted in standard culture medium for
manual cell counts using a hemocytometer. Cell viability was
assessed using Trypan blue dye exclusion. Each proliferation assay
was performed three independent times. Analysis of variance
(ANOVA) Two Factor with Replication was used for analysis. Results
were considered significant if Po0.05.
3H thymidine incorporation assay
SEB-1 sebocytes (passages 21–26) were at 2.5 104 cells per well in
12-well plates and grown until 30–40% confluent. Wells were rinsed
with phosphate-buffered saline (PBS) prior to the addition of 0.1, 0.5,
or 1 mM concentrations of 13-cis RA, 9-cis RA, ATRA, or ethanol
vehicle alone (0.01% or less) in triplicate wells in standard culture
medium. 3H thymidine (1mCi/well) was added a minimum of 8 hours
prior to the end of the treatment period. At the end of the treatment
period, medium was removed and cells were rinsed twice with PBS,
detached using trypsin (0.05%), and collected for liquid scintillation
counting. Each assay was performed a minimum of three indepen-
dent times. Statistical significance was determined with ANOVA
Two Factor with Replication. Results were considered significant if
Po0.05.
Western blot analysis for p21, cyclin D1, and cleaved caspase 3
To confirm results from cell proliferation and apoptosis assays,
protein levels of p21, cyclin D1, and cleaved caspase 3 were
examined using Western blot in our various cell lines. p21, a cyclin-
dependent kinase inhibitor, blocks progression through the G1/S
phase of the cell cycle. Cyclin D1 is specifically required for
progression into S phase. Caspase 3, the key executioner caspase, is
synthesized in the cell as a pro-caspase, which then becomes
cleaved and activated when cells undergo apoptosis. Primary
antibodies for p21 Waf/Cip1 (DCS60), cyclin D1 (DCS6), cleaved
caspase 3 (Asp175), and b-actin and as well as secondary anti-rabbit
IgG horseradish peroxidase antibody were obtained from Cell
Signaling Technology (Beverly, MA). Actin primary antibody and
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anti-mouse horseradish peroxidase-linked secondary antibody were
obtained from Santa Cruz Biotechnology INC (Santa Cruz, CA).
SEB-1 sebocytes (passages 20–26) were grown in 100-mm plates
in standard culture medium until 50–75% confluent. Plates were
rinsed with PBS and then treated with: 13-cis RA (0.1, 1, and 10 mM);
9-cis RA (0.1, 0.5, and 1 mM); ATRA (0.1, 0.5, and 1mM); ethanol
vehicle (0.01% or less) as a negative control; or 1 mM staurosporine
dissolved in ethanol as a positive control. Cells were treated for 24,
48, or 72 hours. NHEK cells (passage 3) were grown in 100-mm
plates in standard culture medium until approximately 50–75%
confluent. Plates were rinsed with PBS and then treated with: 13-cis
RA (0.1, 0.5, and 1mM); ethanol vehicle (0.01% or less); or 1 mM
staurosporine for 2, 4, 6, 18, 24, 48, or 72 hours. Total cell protein
lysates from adherent and floating cells of SEB-1 sebocytes, or NHEK
were collected, flash frozen in liquid nitrogen, and stored at 801C
until needed. Protein concentration of each sample was determined
by the BCA Protein Assay (Pierce, Rockford, IL). Equal amounts of
protein were run on NuPage 10% or 4–12% Bis-Tris Gels with MES
Running Buffer (Invitrogen Life Technologies, Carlsbad, CA). Gels
were transferred to polyvinylidene difluoride membrane, blocked for
1 hour at room temperature in 5% non-fat dry milk, and incubated
with a 1:1,000 dilution of Cleaved Caspase 3 (Asp 175) (5A1) rabbit
monoclonal antibody, 1:1,000 dilution of cyclin D1, or a
1:8,000–15,000 dilution of p21 Waf1/Cip1 (DCS60) mouse mono-
clonal antibody. Secondary anti-rabbit IgG horseradish peroxidase-
linked antibody and anti-mouse horseradish peroxidase-linked
antibody were used to detect primary antibodies. Supersignal West
Pico Chemiluminescent Substrate (Cat no. 34077, Pierce, Rockford,
IL) was used for protein detection. Blots were stripped with Restore
Western Blot Stripping Buffer (Pierce, Rockford IL) and re-probed
with b-actin (no. 4967 Cell Signaling Technologies) or actin (H300
cat no. sc10731) for a loading control. Films of blots were analyzed
and quantified by densitometry with QuantityOne Software (Bio-
Rad, Hercules, CA) after background subtraction. Western blots
were repeated a minimum of three times. Data was analyzed using a
Student’s t-test and results were considered significant if Po0.05.
Annexin V-FITC/propidium iodide FACS apoptosis assay
To determine if 13-cis RA induces apoptosis in SEB-1 sebocytes and
the time course of this effect, the annexin V-FITC FACS assay was
chosen (Martin et al., 1995). Apoptosis assays were performed in
SEB-1 sebocytes, HaCaT keratinocytes, and NHEK that were treated
with 13-cis RA. SEB-1 sebocytes (passages 22–26) and HaCaT
keratinocytes (passages 23–29) were seeded at 8 104 cells per
35-mm plate in their standard culture mediums and allowed to grow
for 3 days, feeding once before treatment. Treatments consisted of:
standard culture medium or ethanol vehicle (0.01% or less) as
negative controls, 1 mM staurosporine as a positive control, and
13-cis RA at a final concentrations of 0.1 or 1 mM in SEB-1 sebocytes
and HaCaT keratinocytes for the initial studies. For follow-up studies
examining a possible 13-cis RA dose–response, SEB-1 sebocytes
were subjected to treatments of: 0.1, 1, 10 nM, 0.1, 1, and 10 mM and
previously mentioned controls. All samples were run in triplicate
and treatments were carried out for 2, 4, 6, 24, 48, and 72 hours. In
parallel experiments, NHEK cells (passage 3) were grown in
keratinocyte growth medium-2 until 70% confluent. Treatments
consisted of ethanol vehicle, 1mM staurosporine, or 13-cis RA (0.1,
0.5, and 1mM). Samples were run in triplicate and assayed at 2, 4, 6,
18, 24, 48, or 72 hours. Each sample was prepared according to BD
ApoAlert Annexin V Protocol (Cat no. K2025-1, BD Biosciences
Clontech, Palo Alto, CA). Ten thousand events were collected per
sample using flow cytometry and debris was excluded by scatter
gating. Single Annexin V-FITC and propidium iodide-stained
samples as well as no-dye-negative control samples determined
quadrants for data analysis. Data analysis was by Cell Quest software
(Becton Dickinson, Canada) and percentage of cells in early
apoptosis, late apoptosis, necrosis, and viable (unaffected) quadrants
were calculated and compared by ANOVA Two Factor with
Replication. Assay was performed three independent times. Results
were considered significant if Po0.05.
TUNEL staining
SEB-1 sebocytes (passages 22–28) were cultured in 12-well plates in
standard medium until approximately 30–40% confluent. Wells
were rinsed with PBS and were treated in triplicate with ethanol
(0.01% or less) as a vehicle control, 13-cis RA, 9-cis RA, or ATRA
each in concentrations of 0.1, 1, or 10 mM. Retinoids were diluted in
standard culture medium and treatments were carried out for 24, 48,
or 72 hours. In parallel experiments, SEB-1 sebocytes (passages
22–24) were cultured in 12-well plates in standard medium until
approximately 30–40% confluent. Wells were rinsed with PBS and
were treated in triplicate with: ethanol (0.01% or less), DMSO
(0.01% or less), or ethanol and DMSO together as vehicle controls,
1mM 13-cis RA alone, 10 mM AGN 193109 alone, or 1mM 13-cis RA
with 10 mM AGN 193109. Additional experiments were performed
with fenretinide, a synthetic retinoid known to induce apoptosis and
act via a retinoid receptor-independent mechanism (Wu et al.,
2001). Fenretinide (4-hydroxyphenyl-retinamide) was handled under
dimmed yellow light and dissolved in 100% ethanol to create a
10 mM stock solution stored at 201C (H 7779 Sigma, St Louis, MO).
SEB-1 sebocytes were treated in triplicate with 0.1, 1, and 10 mM
concentrations. Furthermore, experiments were performed with the
RXR pan agonist CD 3254 (Galderma R&D, Sophia Antipolis,
France). CD 3254 was handled under normal light conditions and
dissolved in DMSO to create a 10 mM stock solution stored at
201C. SEB-1 sebocytes were treated in triplicate with 1 and 50 nM
concentrations. Compounds were diluted in standard culture
medium and applied for 48 or 72 hours. Each well was considered
one sample. Samples were prepared by manufacturer’s instructions
for in situ Cell Death Detection Kit (Roche Applied Science,
Indianapolis, IN). Additional assay controls included negative
controls of labeling solution only and DNase I-treated wells as
positive controls. Results were analyzed and quantified by counting
positive staining cells/total cells in three representative fields per
well for each of the treatments carried out in triplicate. Each assay
was performed three independent times; fenretinide and CD 3254
experiments were repeated twice. Data analysis was performed
using ANOVA Two Factor with Replication and considered
significant if Po0.05.
Quantitative PCR
To verify RAR antagonist activity in TUNEL experiments, quantitative
PCR was used to document downregulation of the RAR target gene,
tazarotene-induced gene 1 (TIG1; retinoic acid receptor responder
1). SEB-1 sebocytes were handled, maintained, and treated with
13-cis RA and RAR antagonist AGN 193109 under experimental
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conditions that were identical to those used in the TUNEL assays.
Total RNA was isolated and quantitative PCR performed as
previously described (Trivedi et al., 2006) Primer – probe sets for
TATA-binding protein (TBP; reference gene), and retinoic acid
receptor responder 1 (TIG1), were purchased from Applied
Biosystems (Foster City, CA) ‘‘no template’’ and ‘‘no amplification’’
controls were included. The Relative Expression Software Tool
(REST-XL) was used for data analysis.
HPLC
13-cis RA is reported to isomerize mainly to ATRA in other cell types
including SZ95 sebocytes (Tsukada et al., 2000). To eliminate the
possibility of an alternative pattern of isomerization and to study the
kinetics of 13-cis RA uptake into SEB-1 sebocytes, we utilized
liquid–liquid extraction, reversed phase HPLC with UV detection.
SEB-1 sebocytes (passage 22) were grown to 80% confluence in 100-
mm plates. For ‘‘medium only’’ controls, SEB-1 medium alone was
placed in 100-mm plates. 5mM 13-cis RA was applied to SEB-1
sebocytes and ‘‘medium only’’ control plates in duplicate for 0, 2, 4,
6, 12, 18, 24, 48, and 72 hours. Experimental samples included
medium collected from ‘‘medium only’’ control plates, medium
from SEB-1 sebocyte plates, and SEB-1 sebocyte cell pellet. Sample
preparation was by liquid–liquid extraction with ethyl acetate. Ethyl
acetate was evaporated and the residue was re-dissolved in a
mixture of acetonitrile and purified water (80/20, vol/vol) before
injection. Internal standard (acitretin), 13-cis RA, 9-cis RA, and
ATRA standards and quality controls solutions were made and
analyzed to generate calibration curve. Samples were injected into
Agilent 1100 Series HPLC system (Agilent Technologies, Palo Alto,
CA) using Nucleosils 100-5 C18 (250 4 mm2) HPLC columns
(Macherey-Nagel Inc., Du¨ren, Germany). Samples were eluted in a
gradient solution composed of purified water and acetonitrile
containing 0.2% acetic acid. Retinoid compounds were detected
by UV detection at 350 nm.
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